Explore
Porta Sophia

Porta Sophia Launches PoliPsy, a Free Real-Time Dashboard Tracking Psychedelic Legislation and Clinical Trials Across the United States

A publicly accessible, automatically updated intelligence platform covering psychedelic policy and research activity, available now at polipsy.dev.

Porta Sophia, a nonprofit public benefit organization focused on psychedelic patent and policy analysis, today launched PoliPsy (polipsy.dev), a free, automatically updated intelligence platform tracking psychedelic legislation and clinical trials across all 50 U.S. states. The platform tracks more than 230 active and historical psychedelic bills and more than 300 registered U.S. clinical trials, updated automatically every morning.

The 2025 legislative session saw more psychedelic-related bills introduced than any prior year, spanning therapeutic access, scheduling changes, clinical research authorizations, decriminalization, and automatic rescheduling frameworks tied to federal drug approval.

PoliPsy at a Glance

  • 230+ bills tracked across all 50 states, including active and historical legislation
  • 300+ registered U.S. clinical trials tracked in real time
  • Updated daily via LegiScan and ClinicalTrials.gov
  • Free and publicly accessible at polipsy.dev
  • Searchable by state, drug type, policy category, bill status, trial phase, and sponsor

Platform Features: Daily-Updated Legislative and Trial Tracking

PoliPsy pulls data daily from the LegiScan legislative tracking site and the ClinicalTrials.gov federal registry, organized through a classification system developed by Porta Sophia’s team. Bills are automatically tagged by drug type (Psilocybin, Ibogaine, MDMA, LSD, DMT, Mescaline), policy category (Scheduling, Therapeutic Access, Trigger Law, Clinical Research, Decriminalization, Legalization), current status, sponsor, and full legislative progress timeline. Clinical trials are tagged by phase, status, sponsor, conditions, and U.S. locations.

The platform offers three core views:

  • Legislation Tracker: Search and filter 230+ bills by state, status, drug type, or policy category, with full progress timelines, sponsor information, and direct links to source documents.
  • Clinical Trials Tracker: Every registered U.S. trial across the full spectrum of psychedelic compounds, from psilocybin and ibogaine to MDMA, LSD, DMT, and proprietary formulations.
  • Analytics View: Legislative activity by state, policy type distribution, drug breakdown, and how the landscape is shifting session over session.

Origin and Mission: Closing the Policy Intelligence Gap

Porta Sophia has spent years analyzing patents and intellectual property trends in the psychedelic space, working to ensure that innovations developed in the public interest remain accessible and that overly broad patent claims do not restrict the development of psychedelic therapies.

“As the legislative landscape accelerated, it became clear that the same analytical rigor we apply to patents needed to be applied to policy,” said Jeremy Rolquin, Chemistry Data Analyst, Porta Sophia. “PoliPsy gives advocates, researchers, and clinicians the infrastructure to understand what is happening across all 50 states simultaneously.”

PoliPsy reflects a consistent Porta Sophia approach: when critical information is difficult to access, build the infrastructure to make it available. The platform is planned for incorporation into the official Porta Sophia website later in 2026.

Intended Users: Advocates, Clinicians, Researchers, and Journalists

PoliPsy is designed for anyone trying to make sense of a policy landscape moving faster than anyone can track manually:

  • Advocates and legislative staff: Real-time bill status, what has passed, and where there is still time to engage.
  • Clinicians, researchers, and academics: Legal framework mapping by state alongside the trial activity being written around it.
  • Journalists: Bill status, legislative history, and cross-state comparison in one place.
  • Industry participants: Landscape intelligence across all compounds and policy frameworks.
Learn about the status and impact of Porta Sophia's third party submissions and observations.

View Our Summary Chart
About Porta Sophia

Porta Sophia, meaning doorway to wisdom, is a non-profit psychedelic prior art library created to support good patents in the field of psychedelics. Based in Madison, Wisconsin USA, Porta Sophia identifies scientific, historical and cultural prior art in common and uncommon spaces and brings it together in one simple search tool for innovators and patent reviewers. The organization's mission is to protect the public domain, stimulate innovation, and support good patents to assure psychedelic therapies can one day be available at scale to the people who need them.

Porta Sophia works to support equity in the psychedelic field. The organization facilitates community engagement through encouraging submissions of prior art from the public and organizing an interdisciplinary Archival Researcher Network (ARN) to ensure quality psychedelic prior art is readily available to patent applicants, examiners, and those interested in psychedelic research.

To learn more about Porta Sophia's patent and prior art workflow or get involved, visit www.portasophia.org.